Polymorphisms in the MUC16 gene: Potential implication in epithelial ovarian cancer

Pathology and Oncology Research

Volumn 17, Issue 2, 2011, Pages 295-299

  Bouanene, Houda ^a   Hadj Kacem, Hassen ^b   Ben Fatma, Leila ^a   Ben Limem, Halima ^a   Ben Ahmed, Slim ^a   Yakoub, Salwa ^c   Miled, Abdelhédi ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^c UR06SP05   (Tunisia)

Author keywords

CA125; Epithelial ovarian cancer; MUC16; Polymorphism

Indexed keywords

CA 125 ANTIGEN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; EPITHELIAL OVARIAN CANCER; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUC16 GENE; OVARY CANCER; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VOLUNTEER;

CA-125 ANTIGEN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80051632586     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9314-2     Document Type: Article

References (20)

1. Boyd J (1998) Molecular genetics of hereditary ovarian cancer. Oncology 12:399-406 (Pubitemid 128617828)
2. Risch HA, McLaughlin JR, Cole D et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700-710 (Pubitemid 32203724)
3. Sekine M, Nagata H, Tsuji S et al (2001) Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-25. Hum Mol Genet 10:1421-1429 (Pubitemid 32640671)
4. Sellers TA, Huang Y, Cunningham J et al (2008) Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 17:397-404 (Pubitemid 351272793)
5. Gubbels J A A, Belisle J, Onda M et al (2006) Mesothelin-MUC16 binding is a high affinity. N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer 5:50
6. Boivin M, Lane D, Piché A et al (2009) CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecol Oncol 115:407-413
7. Belisle J, Gubbels J A A, Raphae CA et al (2007) Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Immunology 122:418-429 (Pubitemid 47556479)
8. Kaneko SJ, Gerasimova T, Smith T et al (2003) CA125 and UQCRFS1 FISH studies of ovarian carcinoma. Gynecol Oncol 90:29-36 (Pubitemid 37338072)
9. O'Brien TJ, Beard JB, Underwood LJ et al (2001) The CA125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biol 22:348-366 (Pubitemid 34062947)
10. Yin B W T, Lloyd KO (2001) Molecular cloning of the CA125 ovarian cancer antigen, identification as a new mucin, MUC16. J Biol Chem 276:27371-27375
11. Porchet N, Aubert JP (2004) Les gènes MUC: mucin or not mucin? That is the question. Med Sci 20:569-574 (Pubitemid 38620601)
12. Gabriel SB, Schaffner SF, Nguyen H et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229 (Pubitemid 34680308)
13. Carlson CS, Eberle MA, Rieder MJ et al (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120 (Pubitemid 38085242)
14. Seelenmeyer C, Wegehingel S, Lechner J et al (2003) The cancer antigen CA125 represents a novel counter receptor for galectin-1. J Cell Sci 116:1305-1318 (Pubitemid 36410668)
15. Rustin GJ, Marples M, Nelstrop AE et al (2001) Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol 19:4054-4057 (Pubitemid 32976692)
16. Hefler LA, Ludwig E, Lebrecht A et al (2002) Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J Soc Gynecol Investig 9:386-390 (Pubitemid 35351343)
17. Wong NK, Easton RL, Panico M et al (2003) Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J Biol Chem 278:28619-28634 (Pubitemid 36935768)
18. Ubell ML, Khampang P, Kerschner JE (2010) Mucin gene polymorphisms in otitis media patients. Laryngoscope 120:132-138
19. Korbi S, Descoteaux-Chatti D (1995) Registre du cancer du centre tunisien, Le cancer dans le centre tunisien, 1er janvier 1987-31 décembre 1993
20. McLemore MR, Aouizerat B (2005) Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer. Biol Res Nur 6:262-267 (Pubitemid 44289595)